{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:44:09Z","timestamp":1792147449032,"version":"4.4.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12012-026-10192-x","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:16:20Z","timestamp":1790014580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Interplay Between Thyroid Cancer and Cardiovascular Disease: Shared Mechanisms, Treatment Implications, and Survivorship Perspectives"],"prefix":"10.1007","volume":"26","author":[{"given":"Leila","family":"Najd-Hassan-Bonab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Moazzam-Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raziyeh","family":"Abooshahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"heydarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1525-8672","authenticated-orcid":false,"given":"Maryam S.","family":"Daneshpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"issue":"25","key":"10192_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: Update from the GBD 2019 study. Journal of the American College of Cardiology,76(25), 2982\u20133021.","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10192_CR2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","volume":"31","author":"CM Kitahara","year":"2022","unstructured":"Kitahara, C. M., & Schneider, A. B. (2022). Epidemiology of thyroid cancer. Cancer Epidemiology, Biomarkers & Prevention,31(7), 1284\u201397. https:\/\/doi.org\/10.1158\/1055-9965.EPI-21-1440","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"12","key":"10192_CR3","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/JAMAOTO.2014.1709","volume":"140","author":"DV Bann","year":"2014","unstructured":"Bann, D. V., Goyal, N., Camacho, F., & Goldenberg, D. (2014). Increasing incidence of thyroid cancer in the Commonwealth of Pennsylvania. JAMA Otolaryngology\u2013Head & Neck Surgery,140(12), 1149\u201356. https:\/\/doi.org\/10.1001\/JAMAOTO.2014.1709","journal-title":"JAMA Otolaryngology\u2013Head & Neck Surgery"},{"issue":"2","key":"10192_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/cen.12724","volume":"84","author":"N Pandeya","year":"2016","unstructured":"Pandeya N, McLeod DS, Balasubramaniam K, Baade PD, Youl PH, Bain CJ, Allison R, Jordan SJ.(2016). Increasing thyroid cancer incidence in Queensland, Australia 1982\u20132008 - True increase or overdiagnosis. Clinical Endocrinology,84(2), 257\u2013264.","journal-title":"Clinical Endocrinology"},{"key":"10192_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/S12889-021-10429-0","author":"M Amini","year":"2021","unstructured":"Amini, M., Zayeri, F., & Salehi, M. (2021). Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: Results from global burden of disease study 2017. BMC Public Health. https:\/\/doi.org\/10.1186\/S12889-021-10429-0","journal-title":"BMC Public Health"},{"issue":"9","key":"10192_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/S41569-024-01017-X","volume":"21","author":"NS Wilcox","year":"2024","unstructured":"Wilcox, N. S., Amit, U., Reibel, J. B., Berlin, E., Howell, K., & Ky, B. (2024). Cardiovascular disease and cancer: Shared risk factors and mechanisms. Nature Reviews Cardiology,21(9), 617\u201331. https:\/\/doi.org\/10.1038\/S41569-024-01017-X","journal-title":"Nature Reviews Cardiology"},{"key":"10192_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/FNUT.2022.1061496","author":"G Asghari","year":"2022","unstructured":"Asghari G, Yuzbashian E, Nikparast A, Najd Hassan Bonab L, Mahdavi M, Daneshpour MS, Hosseinpanah F, Mirmiran P. (2022). Impact of daily vitamin D3 supplementation on the risk of vitamin D deficiency with the interaction of rs2282679 in vitamin D binding protein gene (GC) among overweight and obese children and adolescents: A one-year randomized controlled trial. Frontiers in Nutrition. https:\/\/doi.org\/10.3389\/FNUT.2022.1061496","journal-title":"Frontiers in Nutrition"},{"issue":"1","key":"10192_CR8","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1186\/s12885-020-07401-3","volume":"20","author":"E Izkhakov","year":"2020","unstructured":"Izkhakov E, Keinan-Boker L, Barchana M, Shacham Y, Yaish I, Carmel Neiderman NN, Fliss DM, Stern N, Meyerovitch J (2020). Long-term all-cause mortality and its association with cardiovascular risk factors in thyroid cancer survivors: An Israeli population-based study. BMC Cancer,20(1), 892. https:\/\/doi.org\/10.1186\/s12885-020-07401-3","journal-title":"BMC Cancer"},{"issue":"2","key":"10192_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.14740\/cr1034","volume":"11","author":"R Khan","year":"2020","unstructured":"Khan R, Sikanderkhel S, Gui J, Adeniyi AR, O\u2019Dell K, Erickson M, Malpartida J, Mufti Z, Khan T, Mufti H, Al-Adwan SA. (2020). Thyroid and cardiovascular disease: A focused review on the impact of hyperthyroidism in heart failure. Cardiology Research,11(2), 68\u201375. https:\/\/doi.org\/10.14740\/cr1034","journal-title":"Cardiology Research"},{"key":"10192_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACC.2018.02.045","author":"S Razvi","year":"2018","unstructured":"Razvi S, Jabbar A, Pingitore A, Danzi S, Biondi B, Klein I, Peeters R, Zaman A, Iervasi G. (2018). Thyroid hormones and cardiovascular function and diseases. Journal of the American College of Cardiology. https:\/\/doi.org\/10.1016\/J.JACC.2018.02.045","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10192_CR11","doi-asserted-by":"publisher","first-page":"18438","DOI":"10.1038\/s41598-022-22462-z","volume":"12","author":"MC Tsai","year":"2022","unstructured":"Tsai MC, Hsieh CT, Hsu HY, Yeh TL, Lee WC, Chiang CJ, Hsiao BY, Jhuang JR, Tsai WH, Cheng SP, Chou CL (2022). Association between thyroid cancer and cardiovascular disease risk: A nationwide observation study. Scientific Reports,12(1), 18438. https:\/\/doi.org\/10.1038\/s41598-022-22462-z","journal-title":"Scientific Reports"},{"key":"10192_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2024.101536","volume":"55","author":"NNM Soetedjo","year":"2024","unstructured":"Soetedjo, N. N. M., Agustini, D., & Permana, H. (2024). The impact of thyroid disorder on cardiovascular disease: Unraveling the connection and implications for patient care. IJC Heart & Vasculature, Article 101536. https:\/\/doi.org\/10.1016\/j.ijcha.2024.101536","journal-title":"IJC Heart & Vasculature"},{"issue":"11","key":"10192_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS26115173","volume":"26","author":"A Forma","year":"2025","unstructured":"Forma A, K\u0142odnicka K, Paj\u0105k W, Flieger J, Teresi\u0144ska B, Januszewski J, Baj J(2025). Thyroid cancer: Epidemiology, classification, risk factors, diagnostic and prognostic markers, and current treatment strategies. International Journal of Molecular Sciences,26(11), Article 5173. https:\/\/doi.org\/10.3390\/IJMS26115173","journal-title":"International Journal of Molecular Sciences"},{"key":"10192_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.606931","volume":"12","author":"H Yamakawa","year":"2021","unstructured":"Yamakawa H, Kato TS, Noh JY, Yuasa S, Kawamura A, Fukuda K, Aizawa Y.(2021). Thyroid hormone plays an important role in cardiac function: From bench to bedside. Frontiers in Physiology, Article 606931. https:\/\/doi.org\/10.3389\/fphys.2021.606931","journal-title":"Frontiers in Physiology"},{"issue":"1","key":"10192_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13293-022-00413-7","volume":"13","author":"H Lanjanian","year":"2022","unstructured":"Lanjanian H, Najd Hassan Bonab L, Akbarzadeh M, Moazzam-Jazi M, Zahedi AS, Masjoudi S, Daneshpour MS (2022). Sex, age, and ethnic dependency of lipoprotein variants as the risk factors of ischemic heart disease: A detailed study on the different age-classes and genders in Tehran Cardiometabolic Genetic Study (TCGS). Biol Sex Differ,13(1), 4. https:\/\/doi.org\/10.1186\/s13293-022-00413-7","journal-title":"Biol Sex Differ"},{"key":"10192_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147519","author":"L Najd-Hassan-Bonab","year":"2023","unstructured":"Najd-Hassan-Bonab, L., Givi, N. J., Moazzam-Jazi, M., Masjoudi, S., Ghafari, N., & Daneshpour, M. S. (2023). Sex-specific association of FABP2 polymorphisms with the risk of obesity in the Tehran Cardio-Metabolic Genetic Study (TCGS). Gene. https:\/\/doi.org\/10.1016\/j.gene.2023.147519","journal-title":"Gene"},{"key":"10192_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145485","volume":"778","author":"L Najd Hassan Bonab","year":"2021","unstructured":"Najd Hassan Bonab, L., Moazzam-Jazi, M., Miri Moosavi, R. S., Fallah, M. S., Lanjanian, H., Masjoudi, S.,Daneshpour MS. (2021). Low HDL concentration in rs2048327-G carriers can predispose men to develop coronary heart disease: Tehran Cardiometabolic genetic study (TCGS). Gene,778, Article 145485. https:\/\/doi.org\/10.1016\/j.gene.2021.145485","journal-title":"Gene"},{"key":"10192_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.678326","author":"I Klein","year":"2007","unstructured":"Klein, I., & Danzi, S. (2007). Thyroid disease and the heart. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.678326","journal-title":"Circulation"},{"key":"10192_CR19","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-18-0704","author":"NN Chattergoon","year":"2019","unstructured":"Chattergoon, N. N. (2019). Thyroid hormone signaling and consequences for cardiac development. Journal of Endocrinology. https:\/\/doi.org\/10.1530\/JOE-18-0704","journal-title":"Journal of Endocrinology"},{"key":"10192_CR20","doi-asserted-by":"publisher","DOI":"10.1089\/105072502760143836","author":"S Danzi","year":"2002","unstructured":"Danzi, S., & Klein, I. (2002). Thyroid hormone-regulated cardiac gene expression and cardiovascular disease. Thyroid. https:\/\/doi.org\/10.1089\/105072502760143836","journal-title":"Thyroid"},{"issue":"10","key":"10192_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13102552","volume":"13","author":"C Zhou","year":"2025","unstructured":"Zhou, C., Liu, W., Zheng, J., Wu, Q., & Ai, Z. (2025). Molecular mechanisms of thyroid hormone signaling in thyroid cancer: Oncogenesis, progression, and therapeutic implications. Biomedicines, , Article 2552. https:\/\/doi.org\/10.3390\/biomedicines13102552","journal-title":"Biomedicines"},{"issue":"10","key":"10192_CR22","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1089\/thy.2019.0699","volume":"30","author":"JH Park","year":"2020","unstructured":"Park JH, Choi M, Kim JH, Kim J, Han K, Kim B, Kim DH, Park YG(2020). Metabolic syndrome and the risk of thyroid cancer: A nationwide population-based cohort study. Thyroid,30(10), 1496\u2013504. https:\/\/doi.org\/10.1089\/thy.2019.0699","journal-title":"Thyroid"},{"issue":"11","key":"10192_CR23","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.2337\/dc12-0336","volume":"35","author":"K Esposito","year":"2012","unstructured":"Esposito, K., Chiodini, P., Colao, A., Lenzi, A., & Giugliano, D. (2012). Metabolic syndrome and risk of cancer: A systematic review and meta-analysis. Diabetes Care,35(11), 2402\u20132411. https:\/\/doi.org\/10.2337\/dc12-0336","journal-title":"Diabetes Care"},{"issue":"5","key":"10192_CR24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10552-011-9747-2","volume":"22","author":"M Almquist","year":"2011","unstructured":"Almquist M, Johansen D, Bj\u00f6rge T, Ulmer H, Lindkvist B, Stocks T, Hallmans G, Engeland A, Rapp K, Jonsson H, Selmer R. (2011). Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes & Control,22(5), 743\u201351. https:\/\/doi.org\/10.1007\/s10552-011-9747-2","journal-title":"Cancer Causes & Control"},{"issue":"4","key":"10192_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.pcad.2013.10.016","volume":"56","author":"M Bastien","year":"2014","unstructured":"Bastien, M., Poirier, P., Lemieux, I., & Despr\u00e9s, J. P. (2014). Overview of epidemiology and contribution of obesity to cardiovascular disease. Progress in Cardiovascular Diseases,56(4), 369\u201381. https:\/\/doi.org\/10.1016\/j.pcad.2013.10.016","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"3","key":"10192_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1158\/1055-9965.EPI-10-1220","volume":"20","author":"CM Kitahara","year":"2011","unstructured":"Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, Park Y, Schairer C, Schatzkin A, Shikany JM, Berrington de Gonz\u00e1lez A. (2011). Obesity and thyroid cancer risk among U.S. men and women: A pooled analysis of five prospective studies. Cancer Epidemiology Biomarkers and Prevention,20(3), 464\u2013472. https:\/\/doi.org\/10.1158\/1055-9965.EPI-10-1220","journal-title":"Cancer Epidemiology Biomarkers and Prevention"},{"key":"10192_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-017-0320-7","author":"WG Kim","year":"2018","unstructured":"Kim, W. G., & Cheng, S. (2018). Mechanisms linking obesity and thyroid cancer development and progression in mouse models. Hormones & Cancer. https:\/\/doi.org\/10.1007\/s12672-017-0320-7","journal-title":"Hormones & Cancer"},{"key":"10192_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2025.05.013","author":"D Kounatidis","year":"2025","unstructured":"Kounatidis, D., Vallianou, N. G., Karampela, I., Grivakou, E., & Dalamaga, M. (2025). The intricate role of adipokines in cancer-related signaling and the tumor microenvironment: Insights for future research. Seminars in Cancer Biology. https:\/\/doi.org\/10.1016\/j.semcancer.2025.05.013","journal-title":"Seminars in Cancer Biology"},{"issue":"7","key":"10192_CR29","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/ijc.31172","volume":"142","author":"L Dossus","year":"2018","unstructured":"Dossus L, Franceschi S, Biessy C, Navionis AS, Travis RC, Weiderpass E, Scalbert A, Romieu I, Tj\u00f8nneland A, Olsen A, Overvad K. (2018). Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study. International Journal of Cancer,142(7), 1332\u201342. https:\/\/doi.org\/10.1002\/ijc.31172","journal-title":"International Journal of Cancer"},{"key":"10192_CR30","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2020.0919","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y., Yang, Y., Zhou, T., Li, B., & Wang, Z. (2021). Adiponectin and thyroid cancer: Insight into the association between adiponectin and obesity. Aging and Disease. https:\/\/doi.org\/10.14336\/AD.2020.0919","journal-title":"Aging and Disease"},{"issue":"3","key":"10192_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/mp.54.3.121","volume":"54","author":"V Vella","year":"2001","unstructured":"Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, Vigneri R, Belfiore A. (2001). The IGF system in thyroid cancer: New concepts. Molecular Pathology,54(3), 121\u20134. https:\/\/doi.org\/10.1136\/mp.54.3.121","journal-title":"Molecular Pathology"},{"key":"10192_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00314","volume":"8","author":"R Malaguarnera","year":"2017","unstructured":"Malaguarnera, R., Vella, V., Nicolosi, M. L., & Belfiore, A. (2017). Insulin resistance: Any role in the changing epidemiology of thyroid cancer? Frontiers in Endocrinology, Article 314. https:\/\/doi.org\/10.3389\/fendo.2017.00314","journal-title":"Frontiers in Endocrinology"},{"key":"10192_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13061291","author":"DA Brie","year":"2025","unstructured":"Brie, D. A., Christodorescu, R. M., Popescu, R., Adam, O., T\u00eerziu, A., & Brie, D. M. (2025). Atherosclerosis and insulin resistance: Is there a link between them? Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13061291","journal-title":"Biomedicines"},{"issue":"2","key":"10192_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1089\/thy.2015.0319","volume":"26","author":"CM Kitahara","year":"2016","unstructured":"Kitahara CM, McCullough ML, Franceschi S, Rinaldi S, Wolk A, Neta G, Olov Adami H, Anderson K, Andreotti G, Beane Freeman LE, Bernstein L.(2016). Anthropometric factors and thyroid cancer risk by histological subtype: Pooled analysis of 22 prospective studies. Thyroid,26(2), 306\u201318. https:\/\/doi.org\/10.1089\/thy.2015.0319","journal-title":"Thyroid"},{"issue":"3","key":"10192_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1089\/thy.2021.0445","volume":"32","author":"A Shin","year":"2022","unstructured":"Shin A, Cho S, Jang D, Abe SK, Saito E, Rahman MS, Islam MR, Sawada N, Shu XO, Koh WP, Sadakane A. (2022). Body mass index and thyroid cancer risk: A pooled analysis of half a million men and women in the Asia Cohort Consortium. Thyroid,32(3), 306\u201314. https:\/\/doi.org\/10.1089\/thy.2021.0445","journal-title":"Thyroid"},{"key":"10192_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.12659\/MSM.892035","volume":"21","author":"J Ma","year":"2015","unstructured":"Ma, J., Huang, M., Wang, L., Ye, W., Tong, Y., & Wang, H. (2015). Obesity and risk of thyroid cancer: Evidence from a meta-analysis of 21 observational studies. Medical Science Monitor,21, 283\u2013291.","journal-title":"Medical Science Monitor"},{"issue":"1","key":"10192_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/hr.2010.201","volume":"34","author":"RM Touyz","year":"2011","unstructured":"Touyz, R. M., & Briones, A. M. (2011). Reactive oxygen species and vascular biology: Implications in human hypertension. Hypertension Research,34(1), 5\u201314. https:\/\/doi.org\/10.1038\/hr.2010.201","journal-title":"Hypertension Research"},{"issue":"10","key":"10192_CR38","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","volume":"87","author":"H Cai","year":"2000","unstructured":"Cai, H., & Harrison, D. G. (2000). Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circulation Research,87(10), 840\u2013844. https:\/\/doi.org\/10.1161\/01.RES.87.10.840","journal-title":"Circulation Research"},{"issue":"9","key":"10192_CR39","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1007\/s00467-022-05802-z","volume":"38","author":"D Dro\u017cd\u017c","year":"2023","unstructured":"Dro\u017cd\u017c, D., Dro\u017cd\u017c, M., & W\u00f3jcik, M. (2023). Endothelial dysfunction as a factor leading to arterial hypertension. Pediatric Nephrology,38(9), 2973\u201385. https:\/\/doi.org\/10.1007\/s00467-022-05802-z","journal-title":"Pediatric Nephrology"},{"issue":"3","key":"10192_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/01.HYP.36.3.312","volume":"36","author":"HD Intengan","year":"2000","unstructured":"Intengan, H. D., & Schiffrin, E. L. (2000). Structure and mechanical properties of resistance arteries in hypertension: Role of adhesion molecules and extracellular matrix determinants. Hypertension,36(3), 312\u20138. https:\/\/doi.org\/10.1161\/01.HYP.36.3.312","journal-title":"Hypertension"},{"issue":"48","key":"10192_CR41","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.3760\/cma.j.cn112137-20220611-01299","volume":"102","author":"L Li","year":"2022","unstructured":"Li LJ, Zeng Y, Huang DM, Zhang JM, Zhang H, Ruan XH, Zhao JZ, Gao M, Zheng XQ. (2022). Correlation between dyslipidemia and the risk of papillary thyroid carcinoma. Zhonghua Yi Xue Za Zhi,102(48), 3862\u20133867. https:\/\/doi.org\/10.3760\/cma.j.cn112137-20220611-01299","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10192_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137129","author":"M Lukasiewicz","year":"2024","unstructured":"Lukasiewicz, M., Zwara, A., Kowalski, J., Mika, A., & Hellmann, A. (2024). The role of lipid metabolism disorders in the development of thyroid cancer. International Journal of Molecular Sciences 2024,25(13). https:\/\/doi.org\/10.3390\/ijms25137129","journal-title":"International Journal of Molecular Sciences 2024"},{"key":"10192_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.508126","volume":"10","author":"J Zhao","year":"2021","unstructured":"Zhao J, Tian Y, Yao J, Gu H, Zhang R, Wang H. (2021). Hypercholesterolemia is an associated factor for risk of differentiated thyroid cancer in Chinese population. Frontiers in Oncology,10, Article 508126. https:\/\/doi.org\/10.3389\/fonc.2020.508126","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10192_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41176-4","volume":"13","author":"Z Wang","year":"2023","unstructured":"Wang Z, Yang Y, Xing Y, Si D, Wang S, Lin J, Li C, Zhang J, Yin D (2023). Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma. Scientific Reports,13(1), Article 17666. https:\/\/doi.org\/10.1038\/s41598-023-41176-4","journal-title":"Scientific Reports"},{"key":"10192_CR45","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0002","author":"H Liu","year":"2022","unstructured":"Liu, H., & Peng, D. (2022). Update on dyslipidemia in hypothyroidism: The mechanism of dyslipidemia in hypothyroidism. Endocrine Connections. https:\/\/doi.org\/10.1530\/EC-21-0002","journal-title":"Endocrine Connections"},{"issue":"SUPPL.","key":"10192_CR46","doi-asserted-by":"publisher","first-page":"S376","DOI":"10.1194\/jlr.R800087-JLR200","volume":"50","author":"D Steinberg","year":"2009","unstructured":"Steinberg, D. (2009). The LDL modification hypothesis of atherogenesis: An update. Journal of Lipid Research,50(SUPPL.), S376-81. https:\/\/doi.org\/10.1194\/jlr.R800087-JLR200","journal-title":"Journal of Lipid Research"},{"key":"10192_CR47","doi-asserted-by":"publisher","unstructured":"Papadopoulou, A. M., Bakogiannis, N., Skrapari, I., Moris, D., & Bakoyiannis, C. (2020). Thyroid dysfunction and atherosclerosis: A systematic review. In Vivo. International Institute of Anticancer Research; pp. 3127\u201336. https:\/\/doi.org\/10.21873\/invivo.12147","DOI":"10.21873\/invivo.12147"},{"issue":"2","key":"10192_CR48","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3803\/EnM.2021.1332","volume":"37","author":"J Kim","year":"2022","unstructured":"Kim, J., Kim, M. K., Baek, K. H., Song, K. H., Han, K., & Kwon, H. S. (2022). Repeated low high-density lipoprotein cholesterol and the risk of thyroid cancer: A nationwide population- based study in Korea. Endocrinology and Metabolism,37(2), 303\u2013311. https:\/\/doi.org\/10.3803\/EnM.2021.1332","journal-title":"Endocrinology and Metabolism"},{"issue":"39","key":"10192_CR49","doi-asserted-by":"publisher","first-page":"e27310","DOI":"10.1097\/MD.0000000000027310","volume":"100","author":"G Huang","year":"2021","unstructured":"Huang, G., Lu, H., Li, M., Lv, Q., & Chen, Q. (2021). Association of total cholesterol and atherosclerotic cardiovascular disease in patients with follicular thyroid cancer. Medicine, 100(39), e27310. https:\/\/doi.org\/10.1097\/MD.0000000000027310","journal-title":"Medicine"},{"issue":"4","key":"10192_CR50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.endinu.2022.12.005","volume":"70","author":"P Iglesias","year":"2023","unstructured":"Iglesias, P., & D\u00edez, J. J. (2023). Hyperthyroidism and cardiovascular risk factors: A nationwide study. Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n,70(4), 255\u201361. https:\/\/doi.org\/10.1016\/j.endinu.2022.12.005","journal-title":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"},{"issue":"1","key":"10192_CR51","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","volume":"29","author":"B Biondi","year":"2008","unstructured":"Biondi, B., & Cooper, D. S. (2008). The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews,29(1), 76\u2013131. https:\/\/doi.org\/10.1210\/er.2006-0043","journal-title":"Endocrine Reviews"},{"issue":"3","key":"10192_CR52","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1677\/erc.1.01012","volume":"12","author":"WB Zhong","year":"2005","unstructured":"Zhong, W. B., Liang, Y. C., Wang, C. Y., Chang, T. C., Lee, W. S., & Zhong, W. B. (2005). Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA\/ROCK signaling. Endocrine-Related Cancer,12(3), 615\u201329. https:\/\/doi.org\/10.1677\/erc.1.01012","journal-title":"Endocrine-Related Cancer"},{"issue":"24","key":"10192_CR53","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","volume":"133","author":"CC Low Wang","year":"2016","unstructured":"Low Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016). Clinical update: Cardiovascular disease in diabetes mellitus. Circulation,133(24), 2459\u20132502. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022194","journal-title":"Circulation"},{"issue":"1","key":"10192_CR54","doi-asserted-by":"publisher","first-page":"19860","DOI":"10.1038\/s41598-024-70864-y","volume":"14","author":"S Asgarian","year":"2024","unstructured":"Asgarian S, Lanjanian H, Rahimipour Anaraki S, Hadaegh F, Moazzam-Jazi M, Najd-Hassan-Bonab L, Masjoudi S, Zahedi AS, Zarkesh M, Shalbafan B, Akbarzadeh M(2024). Examining the clinical and genetic spectrum of maturity-onset diabetes of the young (MODY) in Iran. Scientific Reports,14(1), 19860. https:\/\/doi.org\/10.1038\/s41598-024-70864-y","journal-title":"Scientific Reports"},{"issue":"6","key":"10192_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098135","volume":"9","author":"Y Yeo","year":"2014","unstructured":"Yeo Y, Ma SH, Hwang Y, Horn-Ross PL, Hsing A, Lee KE, Park YJ, Park DJ, Yoo KY, Park SK (2014). Diabetes mellitus and risk of thyroid cancer: A meta-analysis. PLoS One,9(6), Article e98135. https:\/\/doi.org\/10.1371\/journal.pone.0098135","journal-title":"PLoS One"},{"issue":"1","key":"10192_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/S12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zu\u00f1iga, F. A. (2018). Association between insulin resistance and the development of cardiovascular disease. Cardiovascular Diabetology,17(1), Article 122. https:\/\/doi.org\/10.1186\/S12933-018-0762-4","journal-title":"Cardiovascular Diabetology"},{"key":"10192_CR57","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/j.atherosclerosis.2021.06.114","volume":"331","author":"NA Van Vliet","year":"2021","unstructured":"Van Vliet NA, Bos MM, Thesing CS, Chaker L, Pietzner M, Houtman E, Neville MJ, Li-Gao R, Trompet S, Mustafa R, Ahmadizar F (2021). Higher thyroid stimulating hormone leads to cardiovascular disease and an unfavorable lipid profile: Evidence from multi-cohort Mendelian randomization and metabolomic profiling. Atherosclerosis,331, e40. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.06.114","journal-title":"Atherosclerosis"},{"key":"10192_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246172","author":"E Kruger","year":"2022","unstructured":"Kruger E, Toraih EA, Hussein MH, Shehata SA, Waheed A, Fawzy MS, Kandil E. (2022). Thyroid carcinoma: A review for 25 years of environmental risk factors studies. Cancers. https:\/\/doi.org\/10.3390\/cancers14246172","journal-title":"Cancers"},{"issue":"7","key":"10192_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16071185","volume":"16","author":"M Fiore","year":"2019","unstructured":"Fiore M, Oliveri Conti G, Caltabiano R, Buffone A, Zuccarello P, Cormaci L, Cannizzaro MA, Ferrante M (2019). Role of emerging environmental risk factors in thyroid cancer: A brief review. International Journal of Environmental Research and Public Health, , Article 1185. https:\/\/doi.org\/10.3390\/ijerph16071185","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"2","key":"10192_CR60","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s12020-025-04441-2","volume":"90","author":"V Sada","year":"2025","unstructured":"Sada V, Cozzolino A, Neri I, Di Lorenzo R, Barba L, Modica R, Dolce P, Achour O, Pozza C, Giannetta E, Gianfrilli D. (2025). Environmental and lifestyle factors and risk of thyroid carcinoma: A cross-sectional study. Endocrine,90(2), 810\u20139. https:\/\/doi.org\/10.1007\/s12020-025-04441-2","journal-title":"Endocrine"},{"issue":"5","key":"10192_CR61","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/J.JACCAO.2025.07.001","volume":"7","author":"L Alhuneafat","year":"2025","unstructured":"Alhuneafat, L., Guha, A., Blaes, A., & Konety, S. H. (2025). Cancer and cardiovascular disease: Shared risk factors, mechanisms, and clinical implications: JACC: CardioOncology state-of-the-art review. Cardio-Oncology,7(5), 453\u201369. https:\/\/doi.org\/10.1016\/J.JACCAO.2025.07.001","journal-title":"Cardio-Oncology"},{"issue":"3","key":"10192_CR62","doi-asserted-by":"publisher","first-page":"173","DOI":"10.15430\/jcp.2020.25.3.173","volume":"25","author":"J Yoon","year":"2020","unstructured":"Yoon, J., & Park, B. (2020). Factors associated with health behaviors in thyroid cancer survivors. Journal of Cancer Prevention,25(3), 173\u2013180. https:\/\/doi.org\/10.15430\/jcp.2020.25.3.173","journal-title":"Journal of Cancer Prevention"},{"issue":"4","key":"10192_CR63","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.canep.2012.03.013","volume":"36","author":"GC Kabat","year":"2012","unstructured":"Kabat, G. C., Kim, M. Y., Wactawski-Wende, J., & Rohan, T. E. (2012). Smoking and alcohol consumption in relation to risk of thyroid cancer in postmenopausal women. Cancer Epidemiology,36(4), 335\u201340. https:\/\/doi.org\/10.1016\/j.canep.2012.03.013","journal-title":"Cancer Epidemiology"},{"issue":"6","key":"10192_CR64","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jaccao.2024.09.013","volume":"6","author":"W Jung","year":"2024","unstructured":"Jung W, Cho IY, Jung J, Cho MH, Koo HY, Park YM, Han K, Shin DW (2024). Changes in physical activity and cardiovascular disease risk in cancer survivors: A nationwide cohort study. JACC: CardioOncology,6(6), 879\u201389. https:\/\/doi.org\/10.1016\/j.jaccao.2024.09.013","journal-title":"JACC: CardioOncology"},{"key":"10192_CR65","doi-asserted-by":"crossref","unstructured":"Klubo-Gwiezdzinska J. A Healthy Lifestyle May Decrease Genetic Predisposition to Thyroid Cancer. Clinical Thyroidology. 2023 Apr;35(4):151-3. https:\/\/www.thyroid.org\/patient-thyroid-information\/ct-for-patients\/may-2023\/vol-16-issue-5-p-3-4\/","DOI":"10.1089\/ct.2023;35.151-153"},{"issue":"25","key":"10192_CR66","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1161\/CIRCULATIONAHA.118.036859","volume":"139","author":"AR Cappola","year":"2019","unstructured":"Cappola AR, Desai AS, Medici M, Cooper LS, Egan D, Sopko G, Fishman GI, Goldman S, Cooper DS, Mora S, Kudenchuk PJ.(2019). Thyroid and cardiovascular disease: Research agenda for enhancing knowledge, prevention, and treatment. Circulation,139(25), 2892\u2013909. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036859","journal-title":"Circulation"},{"issue":"1","key":"10192_CR67","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1530\/EC-20-0539","volume":"10","author":"TP Links","year":"2021","unstructured":"Links, T. P., van der Boom, T., Zandee, W. T., & Lefrandt, J. D. (2021). Cardiovascular effects of overt and subclinical hyperthyroidism: Focus on differentiated thyroid cancer. Endocrine Connections,10(1), R43-51. https:\/\/doi.org\/10.1530\/EC-20-0539","journal-title":"Endocrine Connections"},{"issue":"7","key":"10192_CR68","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1210\/JC.2017-02629","volume":"103","author":"J Park","year":"2018","unstructured":"Park J, Blackburn BE, Ganz PA, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K. (2018). Risk factors for cardiovascular disease among thyroid cancer survivors: Findings from the Utah Cancer Survivors Study. Journal of Clinical Endocrinology and Metabolism,103(7), 2468. https:\/\/doi.org\/10.1210\/JC.2017-02629","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1\u20132","key":"10192_CR69","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1582-4934.2008.00489.x","volume":"14","author":"X Wang","year":"2010","unstructured":"Wang, X., & Sun, Z. (2010). Thyroid hormone induces artery smooth muscle cell proliferation: Discovery of a new TR\u03b11-Nox1 pathway. Journal of Cellular and Molecular Medicine,14(1\u20132), 368\u201380. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00489.x","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10192_CR70","doi-asserted-by":"publisher","DOI":"10.52601\/bpr.2024.240906","author":"B Yang","year":"2024","unstructured":"Yang, B., Wang, S. Q., & Yang, H. Q. (2024). \u03b2-adrenergic regulation of Ca2\u2009+\u2009signaling in heart cells. Biophysics Reports. https:\/\/doi.org\/10.52601\/bpr.2024.240906","journal-title":"Biophysics Reports"},{"key":"10192_CR71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/bs.vh.2023","volume-title":"Vitamins and Hormones","author":"A Hernandez","year":"2023","unstructured":"Hernandez, A., Martinez, M. E., Chaves, C., & Anselmo, J. (2023). Epigenetic developmental programming and intergenerational effects of thyroid hormones. Vitamins and Hormones (pp. 23\u201349). Academic Press Inc. https:\/\/doi.org\/10.1016\/bs.vh.2023"},{"issue":"1","key":"10192_CR72","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1152\/physrev.00038.2019","volume":"101","author":"PJ Davis","year":"2021","unstructured":"Davis, P. J., Mousa, S. A., & Lin, H. Y. (2021). Nongenomic actions of thyroid hormone: The integrin component. Physiological Reviews,101(1), 319\u201352. https:\/\/doi.org\/10.1152\/physrev.00038.2019","journal-title":"Physiological Reviews"},{"issue":"1","key":"10192_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S13105-023-01000-Z","volume":"80","author":"O Casis","year":"2024","unstructured":"Casis, O., Echeazarra, L., S\u00e1enz-D\u00edez, B., & Gallego, M. (2024). Deciphering the roles of triiodothyronine (T3) and thyroid-stimulating hormone (TSH) on cardiac electrical remodeling in clinical and experimental hypothyroidism. Journal of Physiology and Biochemistry,80(1), 1\u20139. https:\/\/doi.org\/10.1007\/S13105-023-01000-Z","journal-title":"Journal of Physiology and Biochemistry"},{"issue":"43","key":"10192_CR74","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.2174\/1381612826666201118094747","volume":"26","author":"M Stojkovi\u0107","year":"2020","unstructured":"Stojkovi\u0107, M., & \u017darkovi\u0107, M. (2020). Subclinical thyroid dysfunction and the risk of cardiovascular disease. Current Pharmaceutical Design,26(43), 5617\u201327. https:\/\/doi.org\/10.2174\/1381612826666201118094747","journal-title":"Current Pharmaceutical Design"},{"issue":"3","key":"10192_CR75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jcjd.2023.01.007","volume":"47","author":"R Shah","year":"2023","unstructured":"Shah, R., Orlov, S., Par\u00e9, G., & Gerstein, H. C. (2023). Thyroid dysfunction and cardiovascular events in patients with dysglycemia. Canadian Journal of Diabetes,47(3), 257\u201362. https:\/\/doi.org\/10.1016\/j.jcjd.2023.01.007","journal-title":"Canadian Journal of Diabetes"},{"key":"10192_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/S13044-015-0021-7","author":"LM O\u2019Keefe","year":"2015","unstructured":"O\u2019Keefe LM, Conway SE, Czap A, Malchoff CD, Benashski S, Fortunato G, Staff I, McCullough LD (2015). Thyroid hormones and functional outcomes after ischemic stroke. Thyroid Research. https:\/\/doi.org\/10.1186\/S13044-015-0021-7","journal-title":"Thyroid Research"},{"issue":"13","key":"10192_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71030","volume":"14","author":"BT Zhang","year":"2025","unstructured":"Zhang, B. T., Guo, M., Yang, L. R., Zeng, Y., & Jiang, J. (2025). Mechanistic aspects of inflammation and oxidative stress and their association with thyroid cancer risk. Cancer Medicine,14(13), Article e71030. https:\/\/doi.org\/10.1002\/cam4.71030","journal-title":"Cancer Medicine"},{"issue":"11","key":"10192_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07166-8","volume":"15","author":"A Ajoolabady","year":"2024","unstructured":"Ajoolabady A, Pratico D, Lin L, Mantzoros CS, Bahijri S, Tuomilehto J, Ren J.(2024). Inflammation in atherosclerosis: Pathophysiology and mechanisms. Cell Death & Disease,15(11), Article 817. https:\/\/doi.org\/10.1038\/s41419-024-07166-8","journal-title":"Cell Death & Disease"},{"key":"10192_CR79","doi-asserted-by":"publisher","first-page":"1552341","DOI":"10.3389\/FONC.2025.1552341\/BIBTEX","volume":"15","author":"Y Yang","year":"2025","unstructured":"Yang, Y., Hu, Z., Ye, Y., Wu, H., Sun, W., & Wang, N. (2025). Association of aggregate index of systemic inflammation with increased all-cause and cardiovascular mortality in female cancer patients. Frontiers in Oncology,15, 1552341. https:\/\/doi.org\/10.3389\/FONC.2025.1552341\/BIBTEX","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10192_CR80","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2025.2580889","volume":"11","author":"J Wu","year":"2025","unstructured":"Wu, J., Chen, Z., Duan, J., & Zhang, G. (2025). Mechanisms and pathways of ROS and autophagy in thyroid cancer. Future Science OA,11(1), Article 2580889. https:\/\/doi.org\/10.1080\/20565623.2025.2580889","journal-title":"Future Science OA"},{"issue":"5","key":"10192_CR81","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/ATVBAHA.117.309228","volume":"37","author":"WN Nowak","year":"2017","unstructured":"Nowak, W. N., Deng, J., Ruan, X. Z., & Xu, Q. (2017). Reactive oxygen species generation and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology,37(5), e41-52. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309228","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10192_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.09.006","author":"S Reuter","year":"2010","unstructured":"Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010). Oxidative stress, inflammation, and cancer: How are they linked? Free Radical Biology & Medicine. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.09.006","journal-title":"Free Radical Biology & Medicine"},{"issue":"11","key":"10192_CR83","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1152\/ajpheart.00907.2011","volume":"302","author":"A Taube","year":"2012","unstructured":"Taube, A., Schlich, R., Sell, H., Eckardt, K., & Eckel, J. (2012). Inflammation and metabolic dysfunction: Links to cardiovascular diseases. American Journal of Physiology, Heart and Circulatory Physiology,302(11), 2148\u201365. https:\/\/doi.org\/10.1152\/ajpheart.00907.2011","journal-title":"American Journal of Physiology, Heart and Circulatory Physiology"},{"issue":"5","key":"10192_CR84","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","volume":"14","author":"KE Bornfeldt","year":"2011","unstructured":"Bornfeldt, K. E., & Tabas, I. (2011). Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metabolism,14(5), 575\u201385. https:\/\/doi.org\/10.1016\/j.cmet.2011.07.015","journal-title":"Cell Metabolism"},{"issue":"10","key":"10192_CR85","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111","volume":"126","author":"JP Despr\u00e9s","year":"2012","unstructured":"Despr\u00e9s, J. P. (2012). Body fat distribution and risk of cardiovascular disease: An update. Circulation,126(10), 1301\u20131313. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111","journal-title":"Circulation"},{"issue":"2","key":"10192_CR86","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000432397","volume":"4","author":"EN Klein Hesselink","year":"2015","unstructured":"Klein Hesselink, E. N., & Links, T. P. (2015). Radioiodine treatment and thyroid hormone suppression therapy for differentiated thyroid carcinoma: Adverse effects support the trend toward less aggressive treatment for low-risk patients. European Thyroid Journal,4(2), 82\u201392. https:\/\/doi.org\/10.1159\/000432397","journal-title":"European Thyroid Journal"},{"key":"10192_CR87","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0311","author":"B Biondi","year":"2010","unstructured":"Biondi, B., & Cooper, D. S. (2010). Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid. https:\/\/doi.org\/10.1089\/thy.2009.0311","journal-title":"Thyroid"},{"key":"10192_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2025.1659736\/PDF","author":"M Pucci","year":"2025","unstructured":"Pucci M, Calzolaio M, Ghezzi F, Iannotta M, Gifuni M, Ruberto S, Crescenzo F, Esposito R, Biondi B.(2025). Cardiovascular risk after total thyroidectomy in patients with differentiated thyroid carcinoma undergoing levothyroxine replacement monotherapy. Frontiers in Endocrinology. https:\/\/doi.org\/10.3389\/FENDO.2025.1659736\/PDF","journal-title":"Frontiers in Endocrinology"},{"key":"10192_CR89","doi-asserted-by":"publisher","DOI":"10.1177\/1178632916689677","volume":"10","author":"MR Palace","year":"2017","unstructured":"Palace, M. R. (2017). Perioperative management of thyroid dysfunction. Health Services Insights, Article 1178632916689677. https:\/\/doi.org\/10.1177\/1178632916689677","journal-title":"Health Services Insights"},{"issue":"3","key":"10192_CR90","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1365-2044.2005.04436.x","volume":"61","author":"SAR Nouraei","year":"2006","unstructured":"Nouraei, S. A. R., Davies, M. R., Obholzer, R., Sandhu, G. S., & Porter, F. (2006). Haemodynamic instability during thyroid surgery: A baroreflex-mediated neurogenic phenomenon? Anaesthesia,61(3), 282\u20134. https:\/\/doi.org\/10.1111\/j.1365-2044.2005.04436.x","journal-title":"Anaesthesia"},{"issue":"7","key":"10192_CR91","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1089\/THY.2021.0634","volume":"32","author":"W Yi","year":"2022","unstructured":"Yi, W., Kim, B. H., Kim, M., Kim, J., Im, M., Ryang, S., Kim, E. H., Jeon, Y. K., Kim, S. S., Kim, I. J. (2022). Heart failure and stroke risks in users of liothyronine with or without levothyroxine compared with levothyroxine alone: A propensity score-matched analysis. Thyroid,32(7), 764\u201371. https:\/\/doi.org\/10.1089\/THY.2021.0634","journal-title":"Thyroid"},{"key":"10192_CR92","doi-asserted-by":"publisher","first-page":"1075844","DOI":"10.3389\/FCVM.2023.1075844","volume":"10","author":"B Biondi","year":"2023","unstructured":"Tsai, W. H., Zeng, Y. H., Lee, C. C., Chien, M.N., Liu, S.C., Chien, K.L., Cheng, S.P., Tseng, P. J., Tsai, M. C. (2023). Association between thyroid cancer and cardiovascular disease: A meta-analysis. Frontiers in Cardiovascular Medicine,10, 1075844\u20131075844. https:\/\/doi.org\/10.3389\/FCVM.2023.1075844","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10192_CR93","doi-asserted-by":"publisher","unstructured":"Roy P, Naskar A, Rahman M, Mandal S, Dhali A, Mukherjee A, Saafan O (2026). Predictors of atherosclerosis and dyslipidaemia among patients with thyroid disease: a cross-sectional analysis. Frontiers in Endocrinology, 17, 1814468. https:\/\/doi.org\/10.3389\/fendo.2026.1814468","DOI":"10.3389\/fendo.2026.1814468"},{"issue":"17","key":"10192_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10174032","volume":"10","author":"CH Kao","year":"2021","unstructured":"Kao CH, Chung CH, Chien WC, Shen DH, Lin LF, Chiu CH, Cheng CY, Sun CA, Chang PY (2021). Radioactive iodine treatment and the risk of long-term cardiovascular morbidity and mortality in thyroid cancer patients: A nationwide cohort study. Journal of Clinical Medicine,10(17), Article 4032. https:\/\/doi.org\/10.3390\/jcm10174032","journal-title":"Journal of Clinical Medicine"},{"issue":"6","key":"10192_CR95","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1210\/jc.2006-2321","volume":"92","author":"S Metso","year":"2007","unstructured":"Metso, S., Jaatinen, P., Huhtala, H., Auvinen, A., Oksala, H., & Salmi, J. (2007). Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. Journal of Clinical Endocrinology and Metabolism,92(6), 2190\u20136. https:\/\/doi.org\/10.1210\/jc.2006-2321","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10192_CR96","first-page":"157","volume":"3","author":"F Thuny","year":"2021","unstructured":"Thuny, F., Alexandre, J., Salem, J. E., Mirabel, M., Dolladille, C., Cohen-Solal, A., Cohen, A., Ederhy, S., Cautela, J., French Working Group of Cardio-Oncology. (2021). Management of immune checkpoint inhibitor\u2013induced myocarditis: the French Working Group\u2019s Plea for a pragmatic approach. Cardio Oncology,3(1), 157\u2013161.","journal-title":"Cardio Oncology"},{"key":"10192_CR97","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0129","author":"MC Hofmann","year":"2022","unstructured":"Hofmann, M. C., Kunnimalaiyaan, M., Wang, J. R., Busaidy, N. L., Sherman, S. I., & Lai, S. Y. (2022). Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers. Endocrine-Related Cancer. https:\/\/doi.org\/10.1530\/ERC-22-0129","journal-title":"Endocrine-Related Cancer"},{"issue":"5","key":"10192_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/OL.2025.15266\/HTML","volume":"30","author":"Z Li","year":"2025","unstructured":"Li Z, Wang N, Li X, Xie Y, Dou Z, Xin H, Lin Y, Si Y, Feng T, Wang G. (2025). Thyroid cancer: From molecular insights to therapy (Review). Oncol Lett, 30(5), 1\u201333. https:\/\/doi.org\/10.3892\/OL.2025.15266\/HTML","journal-title":"Oncol Lett"},{"key":"10192_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02263-4","author":"Y Wan","year":"2025","unstructured":"Wan, Y., Li, G., Cui, G., Duan, S., & Chang, S. (2025). Reprogramming of thyroid cancer metabolism: From mechanism to therapeutic strategy. Molecular Cancer. https:\/\/doi.org\/10.1186\/s12943-025-02263-4","journal-title":"Molecular Cancer"},{"issue":"12","key":"10192_CR100","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1210\/jc.2015-2782","volume":"100","author":"ENK Hesselink","year":"2015","unstructured":"Klein Hesselink EN, Lefrandt JD, Schuurmans EP, Burgerhof JG, Groen B, Gansevoort RT, van der Horst-Schrivers AN, Dullaart RP, Van Gelder IC, Brouwers AH, Rienstra M. (2015). Increased risk of atrial fibrillation after treatment for differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism,100(12), 4563\u20139. https:\/\/doi.org\/10.1210\/jc.2015-2782","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10192_CR101","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1159\/000527272","volume":"31","author":"M Stojanovic","year":"2022","unstructured":"Stojanovic M, Kalezic N, Milicic B, Zivkovic M, Ivosevic T, Lakicevic M, Zivaljevic V.(2022). Risk factors for new onset atrial fibrillation during thyroid gland surgery. Medical Principles and Practice,31(6), 570\u20137. https:\/\/doi.org\/10.1159\/000527272","journal-title":"Medical Principles and Practice"},{"issue":"2","key":"10192_CR102","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jaccao.2021.03.006","volume":"3","author":"JP Yun","year":"2021","unstructured":"Yun JP, Choi EK, Han KD, Park SH, Jung JH, Park SH, Ahn HJ, Lim JH, Lee SR, Oh S. (2021). Risk of atrial fibrillation according to cancer type: A nationwide population-based study. JACC: CardioOncology,3(2), 221\u201332. https:\/\/doi.org\/10.1016\/j.jaccao.2021.03.006","journal-title":"JACC: CardioOncology"},{"issue":"25","key":"10192_CR103","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/eurheartj\/ehae222","volume":"45","author":"Q Chen","year":"2024","unstructured":"Chen Q, van Rein N, van der Hulle T, Heemelaar JC, Trines SA, Versteeg HH, Klok FA, Cannegieter SC. (2024). Coexisting atrial fibrillation and cancer: Time trends and associations with mortality in a nationwide Dutch study. European Heart Journal,45(25), 2201\u201313. https:\/\/doi.org\/10.1093\/eurheartj\/ehae222","journal-title":"European Heart Journal"},{"key":"10192_CR104","doi-asserted-by":"publisher","DOI":"10.1530\/etj-23-0254","author":"G Kostopoulos","year":"2024","unstructured":"Kostopoulos, G., & Effraimidis, G. (2024). Epidemiology, prognosis and challenges in the management of Hyperthyroidism-related Atrial Fibrillation. European Thyroid Journal,13(2). https:\/\/doi.org\/10.1530\/etj-23-0254","journal-title":"European Thyroid Journal"},{"key":"10192_CR105","doi-asserted-by":"publisher","DOI":"10.1210\/JENDSO\/BVAE213","author":"H Qiu","year":"2024","unstructured":"Qiu H, Zhou W, Huang Q, Lin H, Zhou Y, Wu C, Huang Y, Leng J (2024). Role of cancer history in cardiovascular mortality among different age-group patients with differentiated thyroid cancer. Journal of the Endocrine Society. https:\/\/doi.org\/10.1210\/JENDSO\/BVAE213","journal-title":"Journal of the Endocrine Society"},{"key":"10192_CR106","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2024.20.2.12","author":"SWD Fan","year":"2024","unstructured":"Fan, S. W. D., & Ong, L. T. (2024). Prevalence and risk factors of heart failure in patients diagnosed with hyperthyroidism: A systematic review and meta-analysis. touchREVIEWS in Endocrinology. https:\/\/doi.org\/10.17925\/EE.2024.20.2.12","journal-title":"touchREVIEWS in Endocrinology"},{"key":"10192_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.875003","volume":"13","author":"X Meng","year":"2022","unstructured":"Meng X, Wang XL, Zhang ZY, Zhang K, Gao J, Zheng JL, Wang JJ, Liu YP, Yang J, Li C, Zheng YT. (2022). Association between thyroid dysfunction and incidence of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. Frontiers in Endocrinology (Lausanne),13, Article 875003. https:\/\/doi.org\/10.3389\/fendo.2022.875003","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"1","key":"10192_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/s44337-024-00166-9","volume":"1","author":"N Kaouache","year":"2024","unstructured":"Kaouache, N., Lakehal, A., Gavrila, A., & Nouri, N. (2024). Cardiometabolic risk factors among thyroid cancer survivors. Discover Medicine,1(1), Article 140. https:\/\/doi.org\/10.1007\/s44337-024-00166-9","journal-title":"Discover Medicine"},{"key":"10192_CR109","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.90.p522","author":"N Kaouache","year":"2023","unstructured":"Kaouache, N., & Nouri, N. (2023). Cardiovascular health status among thyroid cancer survivors. Endocrine Abstracts. https:\/\/doi.org\/10.1530\/endoabs.90.p522","journal-title":"Endocrine Abstracts"},{"issue":"7","key":"10192_CR110","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1089\/thy.2016.0624","volume":"27","author":"MH Kim","year":"2017","unstructured":"Kim, M. H., Huh, J. Y., Lim, D. J., & Kang, M. I. (2017). Does the risk of metabolic syndrome increase in thyroid cancer survivors? Thyroid,27(7), 936\u201343. https:\/\/doi.org\/10.1089\/thy.2016.0624","journal-title":"Thyroid"},{"issue":"5","key":"10192_CR111","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1530\/ERC-20-0496","volume":"28","author":"G Kostopoulos","year":"2021","unstructured":"Kostopoulos G, Doundoulakis I, Antza C, Bouras E, Nirantharakumar K, Tsiachris D, Thomas GN, Lip GY, Toulis KA. (2021). Incident atrial fibrillation in patients with differentiated thyroid cancer: A meta-analysis. Endocrine-Related Cancer,28(5), 325. https:\/\/doi.org\/10.1530\/ERC-20-0496","journal-title":"Endocrine-Related Cancer"},{"issue":"1","key":"10192_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44701-9","volume":"15","author":"RBTM Sterenborg","year":"2024","unstructured":"Sterenborg RB, Steinbrenner I, Li Y, Bujnis MN, Naito T, Marouli E, Galesloot TE, Babajide O, Andreasen L, Astrup A, \u00c5svold BO. (2024). Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications. Nature Communications,15(1), Article 888. https:\/\/doi.org\/10.1038\/s41467-024-44701-9","journal-title":"Nature Communications"},{"key":"10192_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1425634","volume":"15","author":"Y Shi","year":"2024","unstructured":"Shi Y, Lv C, Liu P, Zheng Y, Zhang H, Dong W, Zhang P. (2024). Relative burden of cancer and noncancer mortality among long-term survivors of differentiated thyroid cancer in the US. Frontiers in Endocrinology (Lausanne),15, Article 1425634. https:\/\/doi.org\/10.3389\/fendo.2024.1425634","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"6","key":"10192_CR114","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/A-2084-3408","volume":"55","author":"J Yu","year":"2023","unstructured":"Yu, J., Kaur, R., Ayeni, F. E., Eslick, G. D., & Edirimanne, S. (2023). Cardiovascular outcomes of differentiated thyroid cancer patients on long term TSH suppression: A systematic review and meta-analysis. Hormone and Metabolic Research,55(6), 379\u201387. https:\/\/doi.org\/10.1055\/A-2084-3408","journal-title":"Hormone and Metabolic Research"},{"key":"10192_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph21030324","author":"JV Abe","year":"2024","unstructured":"Abe JV, Park SY, Haiman CA, Cheng I, Le Marchand L, Hernandez BY, Wilkens LR (2024). Thyroid cancer survival in the multiethnic cohort study. International Journal of Environmental Research and Public Health. https:\/\/doi.org\/10.3390\/ijerph21030324","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"6","key":"10192_CR116","doi-asserted-by":"publisher","first-page":"E878","DOI":"10.1210\/jc.2011-2864","volume":"97","author":"J Jonklaas","year":"2012","unstructured":"Jonklaas J, Nogueras-Gonzalez G, Munsell M, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J (2012). The impact of age and gender on papillary thyroid cancer survival. Journal of Clinical Endocrinology and Metabolism,97(6), E878. https:\/\/doi.org\/10.1210\/jc.2011-2864","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10192_CR117","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf174","author":"L Shobab","year":"2025","unstructured":"Shobab L, Simpson J, McCoy M, Zheng H, Kumari S, Fan R, Budd S, Lee W, Rosen J, Vasko V, Wartofsky L (2025). Differentiated thyroid cancer is associated with sex-specific immune response. Journal of the Endocrine Society. https:\/\/doi.org\/10.1210\/jendso\/bvaf174","journal-title":"Journal of the Endocrine Society"},{"issue":"12","key":"10192_CR118","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1158\/1055-9965.EPI-17-0623","volume":"26","author":"BE Blackburn","year":"2017","unstructured":"Blackburn BE, Ganz PA, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Kim J. (2017). Aging-related disease risks among young thyroid cancer survivors. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology,26(12), 1695\u2013704. https:\/\/doi.org\/10.1158\/1055-9965.EPI-17-0623","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"issue":"5_suppl","key":"10192_CR119","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1200\/jco.2017.35.5_suppl.111","volume":"35","author":"B Blackburn","year":"2017","unstructured":"Blackburn B, Ganz PA, Rowe KG, Wan Y, Deshmukh V, Newman M, Fraser AM, Smith KR, Kim J, Kirchhoff AC, Poruznik C. (2017). Late effects among young thyroid cancer survivors. Journal of Clinical Oncology,35(5_suppl), 111\u2013111. https:\/\/doi.org\/10.1200\/jco.2017.35.5_suppl.111","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10192_CR120","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/S12020-020-02445-8","volume":"72","author":"B Du","year":"2021","unstructured":"Du B, Wang F, Wu L, Wang Z, Zhang D, Huang Z, Gao L, Li Y, Liang C, Li P, Yao R (2021). Cause-specific mortality after diagnosis of thyroid cancer: A large population-based study. Endocrine,72(1), 179\u201389. https:\/\/doi.org\/10.1007\/S12020-020-02445-8","journal-title":"Endocrine"},{"issue":"2","key":"10192_CR121","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1089\/THY.2022.0209","volume":"33","author":"JK Qiang","year":"2023","unstructured":"Qiang, J. K., Alwithenani, R., Uleryk, E., Ezzat, S., Lipscombe, L. L., & Sawka, A. M. (2023). Risk of adverse cardiovascular outcomes in differentiated thyroid cancer survivors: A systematic review and meta-analysis. Thyroid,33(2), 192\u2013202. https:\/\/doi.org\/10.1089\/THY.2022.0209","journal-title":"Thyroid"},{"issue":"8","key":"10192_CR122","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","volume":"35","author":"MD Ringel","year":"2025","unstructured":"Ringel MD, Sosa JA, Baloch Z, Bischoff L, Bloom G, Brent GA, Brock PL, Chou R, Flavell RR, Goldner W, Grubbs EG. (2025). 2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer. Thyroid: Official Journal of the American Thyroid Association,35(8), 841\u2013985.","journal-title":"Thyroid: Official Journal of the American Thyroid Association"},{"issue":"12","key":"10192_CR123","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1089\/CT.2025;37.420-424","volume":"37","author":"JS Mammen","year":"2025","unstructured":"Mammen, J. S., Brenta, G., & Desai, K. (2025). 2025 ATA thyroid cancer guidelines: how low should TSH suppression go? Clinical Thyroidology,37(12), 420\u2013424. https:\/\/doi.org\/10.1089\/CT.2025;37.420-424","journal-title":"Clinical Thyroidology"},{"key":"10192_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2026.1842060","volume":"17","author":"Z Li","year":"2026","unstructured":"Li, Z., Wang, T., & Liu, J. (2026). TSH suppression therapy from an individualized perspective: From mechanism to clinical decision-making. Frontiers in Endocrinology (Lausanne),17, Article 1842060. https:\/\/doi.org\/10.3389\/FENDO.2026.1842060","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"3","key":"10192_CR125","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.eprac.2025.12.002","volume":"32","author":"R Pishdad","year":"2026","unstructured":"Pishdad, R., & Ahmadi, S. (2026). Thyroid-stimulating hormone suppression therapy in thyroid cancer: Balancing benefits and harms. Endocrine Practice,32(3), 401\u20135. https:\/\/doi.org\/10.1016\/j.eprac.2025.12.002","journal-title":"Endocrine Practice"},{"issue":"Supplement_1","key":"10192_CR126","doi-asserted-by":"publisher","first-page":"S216","DOI":"10.2337\/DC26-S010","volume":"49","author":"M Bajaj","year":"2026","unstructured":"Bajaj M, McCoy RG, Balapattabi K, Bannuru RR, Bellini NJ, Bennett AK, Beverly EA, Briggs Early K, ChallaSivaKanaka S, Das SR, Dixon DL (2026). 10. Cardiovascular disease and risk management: Standards of care in diabetes\u20142026. Diabetes Care,49(Supplement_1), S216-45. https:\/\/doi.org\/10.2337\/DC26-S010","journal-title":"Diabetes Care"},{"issue":"41","key":"10192_CR127","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon, A. R., Lopez-Fernandez, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., & Cutter, D. J. (2022Nov 1). 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the International cardio-oncology society (IC-OS) Developed by the task force on cardio-oncology of the European society of cardiology (ESC). European Heart Journal,43(41), 4229\u2013361.","journal-title":"European Heart Journal"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10192-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10192-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10192-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:46:45Z","timestamp":1792144005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10192-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":127,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10192"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10192-x","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"116"}}